Asia Pacific Metagenomics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Asia Pacific Metagenomics Market to 2027 - Regional Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Country

Publication Month: Feb 2019 | Report Code: TIPRE00003320 | No. of Pages: 141 | Category: Biotechnology | Status: Published
The Asia pacific Metagenomics market is expected to reach US$ 61.9 Mn in 2027 from US$ 30.6 Mn in 2018. The market is estimated to grow with a CAGR of 8.5% from 2018-2027.

The growth of the market is driven by the factors such as increasing demand for genomics, growing demand for metagenomics over traditional methods and various applications of metagenomics, in the Asia pacific region. Whereas, expensive techniques of metagenomics is likely to have a negative impact on the growth of the market in the coming years.

In Asia Pacific, the government is supporting more for the genomics and with the support from the government the Chinese players are investing more into the genetic research. The genomics in this region is booming due to the increasing demand for the genetic sequencing. The rise in the Asia’s genomics market is driven by the factors such as rise in the geriatric population, significant growth of the healthcare system and rise in the income of the population. The Chinese government has made compulsion for the data banking of its citizens, the population’s includes genomic data of the people. In addition, a data provided by the Chinese genetics leader BGI states that in China market size of the genetic testing has grown by five times of a market share which is approximately to US$ 925 billion in between 2012 to 2016. Moreover, near around 330 million people of age of 65years and above are anticipated in 2025, therefore the rise in the personalized medicine is expected to grow the market in coming future. Also, investments in the field of genomics is rising For instance, in 2016, the Chinese Academy of Sciences had launched the initiative for precision medicine. Whereas it invested approximately US$ 9 billion to a project that will sequence over 100 million human genomes by 2030. Recently in December 2017, the China’s Ministry of Science and Technology has joined with a human genome research project to document the genetic makeup of 25,000 people.

Owing to growing demand for genomics by the market leaders that enables the access to the metagenomics studies are likely to propel the growth of the market in the forecast period.

China is anticipated to lead the adoptions of Metagenomics across the Asia Pacific region through the forecast period. The metagenomic market in china is anticipated to witness significant growth in the forecast period owing to the extensive conduction of metagenomics. For instance. a project titled as ‘Metagenomic Analysis of Flaviviridae in Mosquito Viromes Isolated From Yunnan Province in China Reveals Genes From Dengue and Zika Viruses’ was conducted. This project was funded by some Chinese entities which include the National Program on Key Research Project of China, Special Fund for Agro-scientific Research in the Public Interest, National Natural Science Foundation of China and others. This project utilized Illumina sequencing to conclude its results.

Exhibit: Rest of Asia Pacific Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)




ASIA PACIFIC METAGENOMICS - MARKET SEGMENTATION

By Product
• Instruments & Software
• Consumables

ASIA PACIFIC METAGENOMICS - MARKET SEGMENTATION

By Application
• Clinical Diagnostics
• Drug Discovery

By Country
• China
• India
• Japan

Companies Mentioned
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Agilent Technologies
• Qiagen
• Bio-Rad Laboratories, Inc.
• Perkinelmer Inc.
• Illumina Inc.
• F Hoffman-La Roche Ltd.
• Oxford Nanopore Technologies Ltd.
• Pacific Bioscience of California, Inc.

PART 1.     iNTRODUCTION

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

PART 2.     Asia pacific Metagenomics Market – Key takeaways

PART 3.     Asia pacific Metagenomics market –  market landscape

3.1       overview

3.2       market segmentation

3.2.1     Asia pacific Metagenomics Market – By Product

3.2.2     Asia pacific Metagenomics Market – By Application

3.2.3     Asia pacific Metagenomics Market – By Country

3.3       PEST Analysis

3.3.1     Asia pacific – PEST Analysis

PART 4.     Asia pacific Metagenomics market- Key Market Dynamics

4.1       Key Market Drivers

4.1.1     Increasing Investments in the field of Metagenomics

4.1.2     Benefits of Metagenomics Over Traditional Methods

4.1.3     Diverse Potential Applications of Metagenomics

4.2       Key Market Restraints

4.2.1     High Cost Associated With Metagenomics

4.3       Key Market Opportunities

4.3.1     Precision Metagenomic Analysis In Personalised Medicine

4.4       Key Market Trends

4.4.1     Growing Trend of  Molecular-Based Approaches

4.5       Impact analysis

PART 5.     Metagenomics market – Asia pacific Analysis

5.1       Asia pacific Metagenomics market Revenue Forecasts and Analysis

5.2       Market positioning

5.3       PERFORMANCE OF KEY PLAYERS

Illumina, Inc.

Qiagen 

5.4       expert opinions

PART 6.     Asia pacific Metagenomics market Analysis –  By Product

6.1       Overview

6.2       ASIA PACIFIC metagenomics MARKET, BY product, 2018 & 2027 (%)

6.3       Asia pacific Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

6.4       Instruments & Software Market

6.4.1     Overview

6.4.2     Asia pacific Instruments & Software Market Revenue and Forecasts to 2027 (US$ Mn)

6.5       Consumables Market

6.5.1     Overview

6.5.2     Asia pacific Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

PART 7.     Asia pacific Metagenomics market Analysis –  By Application

7.1       Overview

7.2       ASIA PACIFIC Metagenomics MARKET, BY application, 2018 & 2027 (%)

7.3       Clinical Diagnostic Market

7.3.1     Overview

7.3.2     Asia pacific Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)

7.4       Drug Discovery metagenomics Market

7.4.1     Overview

7.4.2     Asia pacific Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

7.5       Others Market

7.5.1     Overview

7.5.2     Asia pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

PART 8.     Asia pacific Metagenomics market Revenue and Forecasts  to 2027

8.1       Overview

8.2       Asia pacific metagenomics Market Revenue And Forecasts to 2027, By Country (%)

8.3       US Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)

8.3.1     US Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.2     US Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.3.3     US Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

8.4       Canada Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)

8.4.1     Canada Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.2     Canada Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.4.3     Canada Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

8.5       Mexico Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)

8.5.1     Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.2     Mexico Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.5.3     Mexico Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

PART 9.     Metagenomics Market –Industry Landscape

9.1       Overview

9.2       Growth Strategies in the Metagenomics Market, 2015-2018

9.3       Organic Developments

9.3.1     Overview

9.4       Organic Growth Strategies in the METAGENOMICS Market, 2015-2018

9.5       Product Launch

9.5.1     Recent Product Launch By Players In The Metagenomics Market

9.6       Product approval

9.6.1     Recent Product Approval By Players In The Metagenomics Market

9.7       Expansion & Others

9.7.1     The Metagenomics Market By Expansion & Other Growth Strategies

9.8       Inorganic developments

9.8.1     Overview

9.9       inOrganic Growth Strategies in the Metagenomics Market, 2015-2018

9.10     Acquisitions

9.10.1    Acquisitions By Players In The Metagenomics Market

9.11     Agreements

9.11.1    The Metagenomics Market By Agreements

9.12     Partnership & Collaboration

9.12.1    Partnership By Players In The Metagenomics Market

PART 10.   Metagenomics Market–Key company profiles

10.1     Merck KGaA

10.1.1    Key Facts

10.1.2    Business Description

10.1.3    Financial Overview

10.1.4    Product Portfolio

10.1.5    SWOT Analysis

10.1.6    Key Developments

10.2     Thermo Fisher Scientific, Inc.

10.2.1    Key Facts

10.2.2    Business Description

10.2.3    Financial Information

10.2.4    Product Portfolio

10.2.5    SWOT Analysis

10.2.6    Key Developments

10.3     Agilent Technologies, Inc.

10.3.1    Key Facts

10.3.2    Business Description

10.3.3    Financial Overview

10.3.4    Product Portfolio

10.3.5    SWOT Analysis

10.3.6    Key Developments

10.4     QIAGEN

10.4.1    Key Facts

10.4.2    Business Description

10.4.3    Financial Overview

10.4.4    Product Portfolio

10.4.5    SWOT Analysis

10.4.6    Key Developments

10.5     Bio-Rad Laboratories, Inc.

10.5.1    Key Facts

10.5.2    Business Description

10.5.3    Financial Information

10.5.4    Product Portfolio

10.5.5    SWOT Analysis

10.5.6    Key Developments

10.6     Perkin Elmer, inc.

10.6.1    Key Facts

10.6.2    Business Description

10.6.3    Financial Overview

10.6.4    Product Portfolio

10.6.5    SWOT Analysis

10.6.6    Key Developments

10.7     Illumina, Inc.

10.7.1    Key Facts

10.7.2    Business Description

10.7.3    Financial Overview

10.7.4    Product Portfolio

10.7.5    SWOT Analysis

10.7.6    Key Developments

10.8     F. Hoffmann-La Roche Ltd.

10.8.1    Key Facts

10.8.2    Business Description

10.8.3    Financial Overview

10.8.4    Product Portfolio

10.8.5    SWOT Analysis

10.8.6    Key Developments

10.9     Oxford Nanopore Technologies Ltd.

10.9.1    Key Facts

10.9.2    Business Description

10.9.3    Financial Overview

10.9.4    Product & Services Portfolio

10.9.5    SWOT Analysis

10.9.6    Key Developments

10.10   Pacific Bioscience of California, inc.

10.10.1  Key Facts

10.10.2  Business Description

10.10.3  Financial Overview

10.10.4  Product & Services Portfolio

10.10.5  SWOT Analysis

10.10.6  Key Developments

PART 11.   Appendix

11.1     About The Insight Partners

11.2     Glossary of Terms

11.3     Methodology

11.3.1    Coverage

11.3.2    Secondary Research

11.3.3    Primary Research

 

 

LIST OF TABLES

 

TABLE 1.      Asia pacific Metagenomics market Revenue And Forecasts to 2025, By product (US$ Mn)

TABLE 2.      US Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 3.      US Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 4.      Canada Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 5.      Canada Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 6.      Mexico Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 7.      Mexico Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 8.      Recent Product Launch in the Metagenomics Market

TABLE 9.      Recent Product Approval and Enhancements in the Metagenomics Market

TABLE 10.    the Metagenomics Market by Exansion & Others Strategies

TABLE 11.    Acquisitions in the Metagenomics Market

TABLE 12.    the Metagenomics Market by Agreements

TABLE 13.    partnership in the Metagenomics Market

TABLE 14.    Glossary of Terms, Metagenomics market

 

 

LIST OF FIGURES

 

FIGURE 1.    US Metagenomics market, Revenue (US$ Mn), By 2018 & 2027

FIGURE 2.    Asia pacific Metagenomics Market By product, Market Share (%), 2018

FIGURE 3.    Asia pacific Metagenomics Market By application, Market Share (%), 2018

FIGURE 4.    Metagenomics market Segmentation

FIGURE 5.    Asia pacific PEST Analysis

FIGURE 6.    Metagenomics market impact analysis of drivers & Restraints

FIGURE 7.    Asia pacific Metagenomics market – Revenue Forecasts and Analysis – 2017- 2027

FIGURE 8.    Asia pacific metagenomics market By Product, 2018 & 2027 (%)

FIGURE 9.    Asia pacific Instruments & software Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 10.   Asia pacific Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 11.   Asia pacific Metagenomics market By application, 2018 & 2027 (%)

FIGURE 12.   Asia pacific Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 13.   Asia pacific Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 14.   Asia pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 15.   Asia pacific Metagenomics Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 16.   US Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 17.   Canada Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 18.   Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 19.   Growth Strategies in the Metagenomics Market, 2015-2018

FIGURE 20.   Organic Growth Strategies in the METAGENOMICS Market, 2015-2018

FIGURE 21.   Inorganic developments in the Metagenomics Market, 2015-2018

The List of Companies

  1. Merck KGaA
  2. Thermo Fisher Scientific Inc.
  3. Agilent Technologies
  4. Qiagen
  5. Bio-Rad Laboratories, Inc.
  6. Perkinelmer Inc.
  7. Illumina Inc.
  8. F Hoffman-La Roche Ltd.
  9. Oxford Nanopore Technologies Ltd.
  10. Pacific Bioscience of California, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the metagenomics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global metagenomics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Select License Type
USD $2000
USD $3000
USD $4000
USD $5000